PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-20.47%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$3.84B
AUM Growth
+$3.84B
(-23%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-1.53%
Top 10 Holdings %
Top 10 Hldgs %
54.94%
Holding
138
New
22
Increased
22
Reduced
18
Closed
23
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$67.5M |
| 2 |
Zymeworks
ZYME
|
$41M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$39.1M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$32.3M |
| 5 |
Black Diamond Therapeutics
BDTX
|
$27.6M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$152M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$80.7M |
| 3 |
Neurocrine Biosciences
NBIX
|
$47.5M |
| 4 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
$37.3M |
| 5 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$25.9M |
Sector Composition
| 1 | Healthcare | 95.71% |
| 2 | Technology | 0.27% |
| 3 | Consumer Discretionary | 0.02% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $349M | 9.1% | 11,670,057 +2,253,855 | +24% | +$67.5M |
|
|
GBT
2
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $310M | 8.07% | 6,065,726 +200,000 | +3% | +$10.2M |
|
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $265M | 6.91% | 3,063,263 -549,291 | -15% | -$47.5M |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $255M | 6.65% | 3,319,450 +116,044 | +4% | +$8.92M |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $233M | 6.06% | 25,182,364 +50,000 | +0.2% | +$462K |
|
6
BridgeBio Pharma
BBIO
$9.89B
| $194M | 5.07% | 6,706,268 | – | – |
|
7
Kodiak Sciences
KOD
$478M
| $175M | 4.55% | 3,663,557 | – | – |
|
|
8
Zymeworks
ZYME
$1.12B
| $126M | 3.28% | 3,560,999 +1,157,973 | +48% | +$41M |
|
|
NVRO
9
DELISTED
NEVRO CORP.
NVRO
| $107M | 2.8% | 1,092,068 +328,182 | +43% | +$32.3M |
|
|
SWTX
10
DELISTED
SpringWorks Therapeutics
SWTX
| $94.1M | 2.45% | 3,484,358 +146,836 | +4% | +$3.96M |
|
|
ATNX
11
DELISTED
Athenex, Inc. Common Stock
ATNX
| $89.3M | 2.32% | 11,532,467 | – | – |
|
12
MeiraGTx Holdings
MGTX
$587M
| $86.5M | 2.25% | 6,433,277 | – | – |
|
|
ZGNX
13
DELISTED
Zogenix, Inc.
ZGNX
| $85.4M | 2.22% | 3,452,921 -256,231 | -7% | -$6.34M |
|
|
KDMN
14
DELISTED
Kadmon Holdings, Inc.
KDMN
| $65.8M | 1.71% | 15,711,334 +1,075,000 | +7% | +$4.5M |
|
|
MYOK
15
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $61.6M | 1.6% | 1,314,209 +107,798 | +9% | +$5.05M |
|
16
Korro Bio
KRRO
$217M
| $54M | 1.41% | 3,034,296 | – | – |
|
|
QTNT
17
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $52.5M | 1.37% | 13,289,054 | – | – |
|
18
ADMA Biologics
ADMA
$4.12B
| $47.8M | 1.24% | 16,584,802 +5,063,700 | +44% | +$14.6M |
|
|
VBIV
19
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $43.7M | 1.14% | 45,951,556 | – | – |
|
20
Travere Therapeutics
TVTX
$1.56B
| $42.2M | 1.1% | 2,890,608 | – | – |
|
|
BPMC
21
DELISTED
Blueprint Medicines
BPMC
| $40.3M | 1.05% | 688,624 +70,000 | +11% | +$4.09M |
|
|
22
Regeneron Pharmaceuticals
REGN
$61.5B
| $39.1M | 1.02% | +80,000 | New | +$39.1M |
|
23
Crinetics Pharmaceuticals
CRNX
$2.92B
| $38M | 0.99% | 2,587,953 | – | – |
|
24
Verrica Pharmaceuticals
VRCA
$52.8M
| $37.3M | 0.97% | 3,410,412 | – | – |
|
|
EIDX
25
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $33.7M | 0.88% | 686,922 -10,602 | -2% | -$519K |
|